Company intelligence / Profile preview

Valeo Health

Dubai, United Arab Emiratesvaleoclinics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Valeo Health delivers AI-powered, personalized at-home healthcare solutions across the Gulf Cooperation Council region. Its proprietary Longevity technology enables customized treatment plans based on individual patient data. The company has raised $20 million to date and is expanding its reach throughout Saudi Arabia, UAE, and other GCC countries. No clinical trial results are reported as it does not develop drugs but focuses on service delivery.

Therapeutic areas: Other
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Valeo Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valeo Health.

Explore the full profile